Search Results - "Sega, Emanuela I."
-
1
Tumor detection using folate receptor-targeted imaging agents
Published in Cancer and metastasis reviews (01-12-2008)“…Folate receptors are up-regulated on a variety of human cancers, including cancers of the breast, ovaries, endometrium, lungs, kidneys, colon, brain, and…”
Get full text
Journal Article -
2
Role of lymphocyte activation gene-3 (Lag-3) in conventional and regulatory T cell function in allogeneic transplantation
Published in PloS one (27-01-2014)“…Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg)…”
Get full text
Journal Article -
3
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
Published in Blood (15-09-2008)“…Cytokine-induced killer (CIK) cells are ex vivo–expanded T lymphocytes expressing both natural killer (NK)– and T-cell markers. CIK cells are cytotoxic against…”
Get full text
Journal Article -
4
Rapamycin and IL-2 reduce lethal acute graft-versus-host disease associated with increased expansion of donor type CD4+CD25+Foxp3+ regulatory T cells
Published in Blood (25-08-2011)“…Previous work has demonstrated that both rapamycin (RAPA) and IL-2 enhance CD4+CD25+Foxp3+ regulatory T-cell (Treg) proliferation and function in vitro. We…”
Get full text
Journal Article -
5
Low doses of natural killer T cells provide protection from acute graft-versus-host disease via an IL-4–dependent mechanism
Published in Blood (17-03-2011)“…CD4+ natural killer T (NKT) cells, along with CD4+CD25+ regulatory T cells (Tregs), are capable of controlling aberrant immune reactions. We explored the…”
Get full text
Journal Article -
6
Low-Dose Radiation Potentiates the Therapeutic Efficacy of Folate Receptor–Targeted Hapten Therapy
Published in International journal of radiation oncology, biology, physics (01-06-2008)“…Purpose Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to…”
Get full text
Journal Article -
7
Mast cells suppress murine GVHD in a mechanism independent of CD4+CD25+ regulatory T cells
Published in Blood (21-11-2013)“…To investigate the role of mast cells in hematopoietic cell transplantation, we assessed graft-versus-host disease (GVHD) in C57BL/6-KitW-sh/W-sh recipients,…”
Get full text
Journal Article -
8
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host models
Published in Blood (11-09-2014)“…Acute graft-versus-host disease (GVHD) is induced by alloreactivity of donor T cells toward host antigens presented on antigen-presenting cells (APCs)…”
Get full text
Journal Article -
9
Natural and Expanded CD4+ CD25+ Regulatory T Cells in Bone Marrow Transplantation
Published in Biology of blood and marrow transplantation (2011)Get full text
Journal Article -
10
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease after Bone Marrow Transplantation
Published in Biology of blood and marrow transplantation (01-11-2013)“…Abstract Regulatory T cell (Treg) immunotherapy is a promising strategy for the treatment of graft rejection responses and autoimmune disorders. Our and other…”
Get full text
Journal Article -
11
Role of Lymphocyte Activation Gene-3
Published in PloS one (27-01-2014)“…Lag-3 has emerged as an important molecule in T cell biology. We investigated the role of Lag-3 in conventional T cell (Tcon) and regulatory T cell (Treg)…”
Get full text
Journal Article -
12
The Inhibitory Receptor LAG-3 Is Not Essential for Regulatory T Cells Function but Influences Donor T Cell Potency in Acute Graft-Versus-Host-Disease
Published in Blood (18-11-2011)“…Abstract 1900 GVHD is a major complication of bone marrow transplantation (BMT) and results from donor T cells becoming activated and reacting to host…”
Get full text
Journal Article -
13
IL-17 Gene Ablation Does Not Impact Treg-Mediated Suppression of Graft-Versus-Host Disease Following Bone Marrow Transplantation
Published in Blood (18-11-2011)“…Abstract 4037 Allogeneic hematopoietic cell transplantation (HCT) is an effective treatment for many hematologic malignancies such as leukemia, lymphoma and…”
Get full text
Journal Article -
14
A Novel Model of Pre-Emptive ECP Treatment Shows Significant Reduction of Gvhd-Related Mortality In Mice
Published in Blood (18-11-2011)“…Abstract 4025 Graft versus host disease (Gvhd) remains the major cause of morbidity and mortality after bone marrow transplantation (BMT). To prevent Gvhd the…”
Get full text
Journal Article -
15
Mast Cells Reduce Gvhd Severity In Allogeneic Transplantation by Reducing the Proliferation of Conventional T Cells
Published in Blood (19-11-2010)“…Abstract 243 Mast cells are important effector cells in many innate and adaptive immune responses, and can influence the function of several immune cells…”
Get full text
Journal Article -
16
-
17
Gvhd Severity Is Regulated by the Adoptive Transfer Low Numbers of NKT Cells by a Mechanism Distinct From CD4+CD25+ Regulatory T Cells
Published in Blood (20-11-2009)“…Abstract 229 NKT cells, a subset of which are CD1d reactive, play an important immunoregulatory role in suppressing dysfunctional immune reactions, including…”
Get full text
Journal Article -
18
Rapamycin and IL-2 Prevents Lethal Acute Graft-Versus Host Disease by Expansion of Donor Type CD4+CD25+Foxp3+ Regulatory T Cells
Published in Blood (20-11-2009)“…Abstract 1334 Poster Board I-356 Previous work has demonstrated that both rapamycin (RAPA) and IL-2 enhance CD4+CD25+Foxp3+ regulatory T cells (Treg)…”
Get full text
Journal Article -
19
Functional Comparison of Freshly Isolated and Ex-Vivo Expanded CD4+CD25+Foxp3+ Regulatory T Cells in Suppressing Murine Acute GvHD
Published in Blood (16-11-2008)“…Graft versus host disease (GVHD) is a major complication of hematopoietic stem cell transplantation resulting from donor T cell reactivity against host tissue…”
Get full text
Journal Article -
20
Biology Contribution: Low-Dose Radiation Potentiates the Therapeutic Efficacy of Folate Receptor-Targeted Hapten Therapy
Published in International journal of radiation oncology, biology, physics (01-06-2008)“…Purpose: Human cancers frequently overexpress a high-affinity cell-surface receptor for the vitamin folic acid. Highly immunogenic haptens can be targeted to…”
Get full text
Journal Article